Pfizer shot found fully effective in teens
2021-04-02 00:00
US drugmaker Pfizer on Wednesday reported that a COVID vaccine that it codeveloped was  percent effective against the disease in clinical trials of adolescents.The findings may lead to vaccinations in the United States for middle school students before school starts this fall. The trial subjects were aged from  to .In the Pfizer trial, , minors in the US were enrolled. The vaccine was  percent effective in protecting against symptomatic disease and elicited robust antibody responses one month after the second dose, exceeding those reported in trials of adults in an earlier analysis. Pfizer developed the vaccine with German partner BioNTech.                                                                                                                                                                                                                                                                           !CDATA            function shareweixin              var ua  navigator.userAgent.toLowerCase              ifiphoneipadipod.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyiosschemeencodeIos                            else ifandroid.testua  ua.matchMicroMessengeri  micromessenger                window.opena.app.qq.comosimple.jsp?pkgnamecom.theotino.chinadailyandroidschemeencodeAndroid                            else                window.openwww.chinadaily.com.cnmobiledaily.html